The following contains management's discussion and analysis of our financial
condition and results of operations and should be read together with the
unaudited condensed consolidated financial statements and the related notes
thereto included elsewhere in this Form 10-Q (this "Form 10-Q") and the audited
consolidated financial statements and "Management's Discussion and Analysis of
Financial Condition and Results of Operations" included in our Annual Report on
Form 10-K filed with the Securities and Exchange Commission (the "SEC") on
February 26, 2020 (the "2019 Annual Report on Form 10-K"). This discussion
contains forward-looking statements that reflect our plans, estimates and
beliefs and involve numerous risks and uncertainties, including, but not limited
to, those described in the "Risk Factors" section of the 2019 Annual Report on
Form 10-K and in the "Risk Factors" section of this Form 10-Q, as such risk
factors may be updated from time to time in our periodic filings with the
SEC. Actual results may differ materially from those contained in any
forward-looking statements. You should carefully read "Special Note Regarding
Forward-Looking Statements" in this Form 10-Q.
Overview
We are one of the largest and fastest growing optical retailers in the United
States and a leader in the attractive value segment of the U.S. optical retail
industry. We believe that vision is central to quality of life and that people
deserve to see their best to live their best, no matter what their budget. Our
mission is to make quality eye care and eyewear affordable and accessible to all
Americans. We achieve this by providing eye exams, eyeglasses and contact lenses
to value seeking and lower income consumers. We deliver exceptional value and
convenience to our customers, with an opening price point that strives to be
among the lowest in the industry, enabled by our low-cost operating platform. We
reach our customers through a diverse portfolio of 1,185 retail stores across
five brands and 19 consumer websites as of June 27, 2020.
Recent Developments - COVID-19
The unprecedented and rapid spread of the COVID-19 pandemic and the related
federal, state and local governmental and healthcare authority guidelines have
caused business disruption globally and in the U.S. As of the date of filing of
this Quarterly Report on Form 10-Q, there remain many uncertainties regarding
the COVID-19 pandemic and its resurgence, including the anticipated duration of
the pandemic and the extent of national and global social and economic
disruption it may cause. To date, the COVID-19 pandemic and government and
healthcare authority actions to curb the spread of the virus have had
far-reaching impacts, directly and indirectly, on our operations, including the
temporary closure of our stores to the public between March and June 2020, and
on consumer behavior, comparable store sales, our employees and optometrists,
and the overall market. The scope and nature of these impacts continue to evolve
on a daily basis. The COVID-19 pandemic has resulted in, and may continue to
result in, state, city or local quarantines, labor stoppages and shortages,
changes in consumer purchasing patterns, mandatory or voluntary shut-downs of
retail locations, severe market volatility, liquidity disruptions, and overall
economic instability, which, in many cases, have had, and we expect will
continue to have, material adverse impacts on our business, financial condition
and results of operations. This situation is rapidly changing, and additional
impacts may arise that we are not aware of currently. In response to the
evolving and uncertain situation, we have taken aggressive and prudent actions
to minimize the risk to our Company, employees, customers and the communities in
which we operate, along with reducing expenses and deferring discretionary
capital expenditures. Some of our actions taken include:
Operational
•On March 19, 2020, we temporarily closed all of our stores to the public across
the United States; on April 23, 2020, we announced plans to reopen stores
selectively over the coming weeks; and on June 8, 2020, we announced that we had
successfully completed the reopening process with enhanced safety and cleaning
protocols.
•During April and May 2020, we temporarily furloughed a significant portion of
our employees, bringing most back when we reopened in early June.
•While our stores were closed to the public, our retail locations continued to
provide services as associates remained available by phone for patients and
customers in need, and where possible, we shipped eyeglasses and contact lenses
from our labs and distribution centers directly to customers who had placed
orders in our stores and otherwise would have picked them up in our stores. In
addition, the Company's e-commerce websites remained fully operational.
•We have suspended all non-essential travel for our employees.
                                       29
--------------------------------------------------------------------------------
  Table of Contents
•Following the successful reopening of our stores, we continually assess the
evolving COVID-19 situation and, where appropriate, have taken, or may take in
the future, actions such as reducing store hours, reducing patient appointments
or temporarily closing stores.
Financial
•On March 17, 2020, as a precautionary measure to preserve financial flexibility
during the COVID-19 pandemic, we borrowed the remaining $146.3 million in
available funds under our revolving credit facility; and, as described below, on
May 12, 2020, we repaid the full amount outstanding under our revolving credit
facility.
•Effective May 5, 2020, we entered into an amendment ("Credit Agreement
Amendment") of our Amended and Restated Credit Agreement, dated as of July 18,
2019 facility ("Credit Agreement,") which is intended to prevent the effects of
the COVID-19 pandemic, including the temporary closure of our stores, from
creating uncertainty relative to our ability to comply with certain financial
covenants and allow the Company to focus on prudent management of the business
over the quarters ahead. The Credit Agreement Amendment suspends certain
financial maintenance covenants contained in the facility until testing at the
end of the second fiscal quarter of 2021. As part of the Credit Agreement
Amendment, the Company among other things agreed to modify the rate of interest
paid under the facility and to limit its ability to engage in certain
transactions during the covenant suspension period, including the ability to
declare or pay dividends, incur additional debt and make investments and
dispositions.
•On May 12, 2020, we completed the issuance of 2.50% convertible senior notes
due on May 15, 2025 (the "2025 Notes"), pursuant to an indenture (the
"Indenture"), and we used the net proceeds of this offering to repay our
outstanding borrowings on our term loan and revolving credit facility. We
continue to prioritize cash conservation and prudent use of cash, while
positioning the Company to safely conduct normal operations.
•Beginning in March 2020, we implemented capital spending and expense reduction
initiatives including a temporary pause in new store openings, reduced near term
marketing spend, reduced compensation and work hours across the organization and
working with a base of vendors and landlords to extend payment terms and modify
existing contracts; in the second quarter of 2020 we resumed store openings
concurrent with the reopening of existing stores and suspended compensation
reductions.
The COVID-19 pandemic and responsive measures taken by the Company have had, and
may continue to have, material adverse impacts on our current business,
financial condition and results of operations, and may create additional risks
for our Company. While we anticipate that these measures are temporary, their
specific duration has a high degree of uncertainty and we may elect or need to
take additional measures as the situation continues to evolve, including with
respect to our store operations, employees, store leases and relationships with
third-party vendors. We continue to assess the evolving COVID-19 pandemic and
its impact on our customers, employees, optometrists, supply chain and
operations and will adjust our responsive measures accordingly. However, the
extent to which the COVID-19 pandemic and our precautionary measures in response
thereto may impact our business, financial condition and results of operations
will depend on how the pandemic and its impacts continue to develop, which are
highly uncertain. We are continuing to evaluate additional operational and
financial measures that we may elect to take as we continue to respond to the
impact of COVID-19 on our business. There can be no assurance whether or when
any such measures will be adopted.
The disclosures contained in this Form 10-Q are made only as of the date hereof,
and we undertake no obligation to publicly update or revise any forward-looking
statement as a result of new information, future events or otherwise, except as
required by law. For further information, please see "Risk Factors" and
"Forward-Looking Statements."
                                       30
--------------------------------------------------------------------------------
  Table of Contents
Brand and Segment Information
Our operations consist of two reportable segments:
•Owned & Host - As of June 27, 2020, our owned brands consisted of 753 America's
Best Contacts and Eyeglasses ("America's Best") retail stores and 118 Eyeglass
World retail stores. In America's Best stores, vision care services are provided
by optometrists employed by us or by independent professional corporations or
similar entities. America's Best stores are primarily located in high-traffic
strip centers next to value-focused retailers. Eyeglass World locations
primarily feature vision care services provided by independent optometrists and
optometrists employed by independent professional corporations or similar
entities and on-site optical laboratories that enable stores to quickly fulfill
many customer orders and make repairs on site. Eyeglass World stores are
primarily located in freestanding or in-line locations near high-foot-traffic
shopping centers. Our host brands consisted of 54 Vista Optical locations on
military bases and 29 Vista Optical locations within Fred Meyer stores as of
June 27, 2020. We have strong, long-standing relationships with our host
partners and have maintained each partnership for over 20 years. These brands
provide eye exams primarily by independent optometrists. All brands utilize our
centralized laboratories. This segment also includes sales from our America's
Best, Eyeglass World, and Military omni-channel websites.
•Legacy - We manage the operations of, and supply inventory and laboratory
processing services to, 231 Vision Centers in Walmart retail locations as of
June 27, 2020. This strategic relationship with Walmart is in its 30th year.
Pursuant to a January 2020 amendment to our management & services agreement with
Walmart, we added five additional Vision Centers in Walmart stores in fiscal
year 2020. Refer to Note 14. "Subsequent Events" included in Part I. Item 1. of
this Form 10-Q for further information on the contract amendment to extend the
current term and economics of the management and services agreement by three
years to February 23, 2024. Under the management & services agreement, our
responsibilities include ordering and maintaining merchandise inventory;
arranging the provision of optometry services; providing managers and staff at
each location; training personnel; providing sales receipts to customers;
maintaining necessary insurance; obtaining and holding required licenses,
permits and accreditations; owning and maintaining store furniture, fixtures and
equipment; and developing annual operating budgets and reporting. We earn
management fees as a result of providing such services and therefore we record
revenue related to sales of products and product protection plans to our legacy
partner's customers on a net basis. Our management & services agreement also
allows our legacy partner to collect penalties if the Vision Centers do not
generate a requisite amount of revenues. No such penalties have been assessed
under our current arrangement, which began in 2012. We also sell to our legacy
partner merchandise that is stocked in retail locations we manage pursuant to a
separate supplier agreement, and provide centralized laboratory services for the
finished eyeglasses for our legacy partner's customers in stores that we manage.
We lease space from Walmart within or adjacent to each of the locations we
manage and use this space for vision care services provided by independent
optometrists or optometrists employed by us or by independent professional
corporations or similar entities. During the six months ended June 27, 2020,
sales associated with our legacy partner arrangement represented 8.5% of
consolidated net revenue. This exposes us to concentration of customer risk.

                                       31
--------------------------------------------------------------------------------
  Table of Contents
Our consolidated results also include the following activity recorded in our
Corporate/Other category:
•Our e-commerce platform of 15 dedicated websites managed by AC Lens. Our
e-commerce business consists of six proprietary branded websites, including
aclens.com, discountglasses.com and discountcontactlenses.com, and nine
third-party websites with established retailers, such as Walmart, Sam's Club and
Giant Eagle as well as mid-sized vision insurance providers. AC Lens handles
site management, customer relationship management and order fulfillment and also
sells a wide variety of contact lenses, eyeglasses and eye care accessories.
•AC Lens also distributes contact lenses wholesale to Walmart and Sam's Club. We
incur costs at a higher percentage of sales than other product categories. AC
Lens sales associated with Walmart and Sam's Club contact lenses distribution
arrangements represented 8.6% of consolidated net revenue.
•Managed care business conducted by FirstSight, our wholly-owned subsidiary that
is licensed as a single-service health plan under California law, which arranges
for the provision of optometric services at the offices next to certain Walmart
stores throughout California, and also issues individual vision care benefit
plans in connection with our America's Best operations in California.
•Unallocated corporate overhead expenses, which are a component of selling,
general and administrative expenses and are comprised of various home office
expenses such as payroll, occupancy costs, and consulting and professional fees.
Corporate overhead expenses also include field services for our five retail
brands.
Reportable segment information is presented on the same basis as our
consolidated financial statements, except reportable segment sales which are
presented on a cash basis including point of sales for managed care payors and
excluding the effects of unearned and deferred revenue, consistent with what our
chief operating decision maker ("CODM") regularly reviews. Reconciliations of
segment results to consolidated results include financial information necessary
to adjust reportable segment revenues to a consolidated basis in accordance with
U.S. GAAP, specifically the change in unearned and deferred revenues during the
period. There are no revenue transactions between reportable segments, and there
are no other items in the reconciliations other than the effects of unearned and
deferred revenue. See Note 10. "Segment Reporting" in our consolidated financial
statements included in Part I. Item 1. of this Form 10-Q.
Deferred revenue represents the timing difference of when we collect the cash
from the customer and when services related to product protection plans and eye
care club memberships are performed. Increases or decreases in deferred revenue
during the reporting period represent cash collections in excess of or below the
recognition of previous deferrals. Unearned revenue represents the timing
difference of when we collect cash from the customer and delivery/customer
acceptance, and includes sales of prescription eyewear during approximately the
last seven to 10 days of the reporting period.
Trends and Other Factors Affecting Our Business
COVID-19 Impact
The COVID-19 pandemic has had far-reaching impacts, directly and indirectly, on
our operations. We are continuing to monitor the impacts COVID-19 has had, and
continues to have, on our outsourced third party optical laboratories in China
and Mexico, including potential disruptions of product deliveries. To date, we
have been able to meet customer demand with operations at our laboratories. We
source merchandise from suppliers located in China and a significant amount of
domestically-purchased merchandise is manufactured in China. We have partnered
with our suppliers and third party laboratories to mitigate any potential
significant delays in delivery of merchandise upon store operations resuming.
Our e-commerce business remained open to serve our customers during the
unprecedented period of temporary store closures.
We incurred $2.5 million and $3.1 million of costs in the three and six months
ended June 27, 2020, respectively, primarily for personal protective equipment
and other supplies needed to operate our stores safely, as well as for
professional fees associated with adapting our operations to the COVID-19
pandemic. Incremental expenses related to the COVID-19 pandemic are not
allocated to the reportable segments, but are included in the Corporate/Other
category.
                                       32
--------------------------------------------------------------------------------
  Table of Contents
We have seen, and may continue to see, material reductions in sales across
brands and regions as a result of the COVID-19 pandemic. In addition, these
reductions in revenue have not been offset by proportional decreases in expense,
as we continued to incur store occupancy costs even while stores were
temporarily closed, incremental costs directly related to adapting the Company's
operations to the COVID-19 pandemic and certain other costs such as compensation
and administrative expenses, resulting in a negative effect on profitability. In
addition, we could experience further material impacts as a result of COVID-19,
including, but not limited to, charges from additional asset impairment,
deferred tax valuation allowances and further changes in the effectiveness of
our hedging instruments. The current circumstances are dynamic and the impacts
of COVID-19 on our business operations, including the duration and impact on
overall customer demand, are highly uncertain, although COVID-19 has had, and
may continue to have, a material adverse impact on our business, results of
operations, financial condition and cash flows in fiscal 2020 to date and
beyond.
The Company recorded a credit totaling $10.8 million as a result of the employee
retention credits made available under the CARES Act for US employees during the
three and six months ended June 27, 2020, recognizing $0.4 million as a
reduction to costs of products, $6.2 million as a reduction to costs of services
and plans, and $4.2 million as a reduction to SG&A.
It is possible that our preparations for the events listed above are not
adequate to mitigate their impact, and that these events could further adversely
affect our business and results of operations. For a discussion of significant
risks that have the potential to cause our actual results to differ materially
from our expectations, refer to "Item 1A. Risk Factors," included in our 2019
Annual Report on Form 10-K and in this Form 10-Q.
Other developments
As a result of the U.S. government's temporary reduction of tariff rates
affecting certain of our products that originate in China, we recognized an
immaterial reduction in costs of products for the three and six months ended
June 27, 2020. We currently expect this tariff reduction to be partial and
temporary. Additionally, we are monitoring ongoing political developments
between China and the United States. A worsening of relations could lead to the
early reinstatement of existing tariffs, or the imposition of additional
tariffs, or may cause other disruptions in our supply of products from China.
Long-term trends and factors
We remain committed to our long-term vision and continue to position ourselves
to make progress against our key initiatives while balancing the near-term
challenges and unprecedented uncertainty presented by the COVID-19 pandemic. As
a result of the COVID-19 pandemic, we implemented capital spending and expense
reduction initiatives including a temporary pause in new store openings, reduced
near term marketing spend, and reduced compensation and work hours across the
organization and are working with a base of vendors and landlords to extend
payment terms and modify existing contracts. We have also incurred incremental
costs directly related to adapting the Company's operations to the COVID-19
pandemic. We experienced negative comparable store sales growth in the first
half of 2020 as a result of the closure of our stores in response to the
COVID-19 pandemic, and anticipate that comparable store sales growth figures for
the fiscal years 2020 and 2021 will be impacted by the pandemic. We believe that
the following areas will continue to be affected and relevant risk exposures may
be exacerbated by the immediate and ongoing threat of the COVID-19 pandemic:
•New store openings;
•Comparable store sales growth;
•Managed care and insurance;
•Vision care professional recruitment and coverage;
•Overall economic trends;
•Consumer preferences and demand;
•Infrastructure and investment;
•Pricing strategy;
•Inflation;
•Interim results and seasonality;
•Competition; and
•Consolidation in the industry
                                       33
--------------------------------------------------------------------------------
  Table of Contents
How We Assess the Performance of Our Business
While we have historically attempted to exercise prudence in our use of cash,
the COVID-19 pandemic has required us to closely monitor various items related
to cash flow including, but not limited to, cash receipts, cash disbursements,
payment terms and alternative sources of funding. We will continue to be focused
on these items in addition to the other key measures we use to determine how our
consolidated business and operating segments are performing, including: net
revenue, costs applicable to revenue, and selling, general, and administrative
expenses. In addition, we also review store growth, Adjusted Comparable Store
Sales Growth, Adjusted Operating Income, Adjusted Operating Margin, Adjusted
EBITDA, Adjusted EBITDA Margin and Adjusted Diluted EPS.
Net Revenue
We report as net revenue amounts generated in transactions with retail customers
who are the end users of our products, services, and plans. Net product sales
include sales of prescription and non-prescription eyewear, contact lenses, and
related accessories as well as eye exam services associated with our America's
Best brand's signature offer of two pairs of eyeglasses and a free eye exam for
one low price ("two-pair offer") to retail customers and sales of inventory in
which our customer is another retail entity. Net sales of services and plans
include sales of eye exams, eye care club memberships, product protection plans
(i.e., warranties), and single service eye care plans in California. Net sales
of services and plans also include fees we earn for managing certain Vision
Centers located in Walmart stores and for laboratory services provided to
Walmart.
Costs Applicable to Revenue
Costs applicable to revenue include both costs of net product sales and costs of
net sales of services and plans. Costs of net product sales include (i) costs to
procure non-prescription eyewear, contact lenses, and accessories, which we
purchase and sell in finished form, (ii) costs to manufacture finished
prescription eyeglasses, including direct materials, labor, and overhead, and
(iii) remake costs, warehousing and distribution expenses, and internal transfer
costs. Costs of services and plans include costs associated with product
protection plan programs, eye care club memberships, single service eye care
plans in California, eye care practitioner and eye exam technician payroll,
taxes and benefits and optometric and other service costs. Customer tastes and
preferences, product mix, changes in technology, significant increases or
slowdowns in production, and other factors impact costs applicable to revenue.
The components of our costs applicable to revenue may not be comparable to other
retailers.
Selling, General and Administrative
Selling, general and administrative expenses, or SG&A, include store associate
(including optician) payroll, taxes and benefits, occupancy, advertising and
promotion, field services, corporate support and other costs associated with the
provision of vision care services. Non-capital expenditures associated with
opening new stores, including rent, store maintenance, marketing expenses,
travel and relocation costs, and training costs, are recorded in SG&A as
incurred. SG&A generally fluctuates consistently with revenue due to the
variable store, field office and corporate support costs; however, some fixed
costs slightly improve as a percentage of net revenue as our net revenues grow
over time.
New Store Openings
The total number of new stores per year and the timing of store openings has,
and will continue to have, an impact on our results. In an effort to conserve
cash during the COVID-19 pandemic, we temporarily paused new store openings
during a portion of the six months ended June 27, 2020. We expect to open
approximately 50 to 55 stores in the current year. We will continue to monitor
and determine our plans for future new store openings based on based on health,
safety and economic conditions.
                                       34
--------------------------------------------------------------------------------
  Table of Contents
Adjusted Comparable Store Sales Growth
We measure Adjusted Comparable Store Sales Growth as the increase or decrease in
sales recorded by the comparable store base in any reporting period, compared to
sales recorded by the comparable store base in the prior reporting period, which
we calculate as follows: (i) sales are recorded on a cash basis (i.e., when the
order is placed and paid for or submitted to a managed care payor, compared to
when the order is delivered), utilizing cash basis point of sale information
from stores; (ii) stores are added to the calculation during the 13th full
fiscal month following the store's opening; (iii) closed stores are removed from
the calculation for time periods that are not comparable; (iv) sales from
partial months of operation are excluded when stores do not open or close on the
first day of the month; and (v) when applicable, we adjust for the effect of the
53rd week. Quarterly, year-to-date and annual adjusted comparable store sales
are aggregated using only sales from all whole months of operation included in
both the current reporting period and the prior reporting period. When a partial
month is excluded from the calculation, the corresponding month in the
subsequent period is also excluded from the calculation. There may be variations
in the way in which some of our competitors and other retailers calculate
comparable store sales. As a result, our adjusted comparable store sales may not
be comparable to similar data made available by other retailers. We did not
adjust our calculation of Adjusted Comparable Store Sales Growth for the
temporary closure of our stores to the public as a result of the COVID-19
pandemic.
Adjusted Comparable Store Sales Growth is a non-GAAP financial measure, which we
believe is useful because it provides timely and accurate information relating
to the two core metrics of retail sales: number of transactions and value of
transactions. We use Adjusted Comparable Store Sales Growth as the basis for key
operating decisions, such as allocation of advertising to particular markets and
implementation of special marketing programs. Accordingly, we believe that
Adjusted Comparable Store Sales Growth provides timely and accurate information
relating to the operational health and overall performance of each brand. We
also believe that, for the same reasons, investors find our calculation of
Adjusted Comparable Stores Sales Growth to be meaningful.
Adjusted EBITDA, Adjusted EBITDA Margin Adjusted Operating Income, Adjusted
Operating Margin, and Adjusted Diluted EPS (collectively, the "Company Non-GAAP
Measures")
The Company Non-GAAP Measures are key measures used by management to assess our
financial performance. The Company Non-GAAP Measures are also frequently used by
analysts, investors and other interested parties. We use The Company Non-GAAP
Measures to supplement U.S. GAAP measures of performance to evaluate the
effectiveness of our business strategies, to make budgeting decisions, to
establish discretionary annual incentive compensation and to compare our
performance against that of other peer companies using similar measures. See
"Non-GAAP Financial Measures" for definitions of the Company Non-GAAP Measures
and for additional information.

                                       35
--------------------------------------------------------------------------------
  Table of Contents
Results of Operations
The following table summarizes key components of our results of operations for
the periods indicated, both in dollars and as a percentage of our net revenue.
                                                                  Three Months Ended                                             Six Months Ended
In thousands, except store data                          June 27, 2020          June 29, 2019          June 27, 2020           June 29, 2019

Revenue:


Net product sales                                       $     209,707

$ 357,533 $ 602,548 $ 740,693 Net sales of services and plans

                                50,300                 71,918                127,163                  149,973
Total net revenue                                             260,007                429,451                729,711                  890,666
Costs applicable to revenue (exclusive of depreciation
and amortization):
Products                                                       97,635                145,654                254,005                  299,658
Services and plans                                             43,145                 56,852                105,329                  114,817
Total costs applicable to revenue                             140,780                202,506                359,334                  414,475
Operating expenses:
Selling, general and administrative expenses                  136,582                182,278                330,323                  376,154
Depreciation and amortization                                  21,924                 20,819                 46,734                   41,234
Asset impairment                                                2,411                  1,790                 13,766                    3,872
Litigation settlement                                               -                      -                  4,395                        -
Other expense (income), net                                       (92)                   356                   (158)                     829
Total operating expenses                                      160,825                205,243                395,060                  422,089
Income (loss) from operations                                 (41,598)                21,702                (24,683)                  54,102
Interest expense, net                                          15,502                  8,968                 22,957                   18,029
Debt issuance costs                                               136                      -                    136                        -
Earnings (loss) before income taxes                           (57,236)                12,734                (47,776)                  36,073
Income tax provision (benefit)                                (13,403)                 2,477                (13,685)                   8,387
Net income (loss)                                       $     (43,833)         $      10,257          $     (34,091)         $        27,686

Operating data:
Number of stores open at end of period                          1,185                  1,128                  1,185                    1,128
New stores opened                                                  17                     24                     40                       50
Adjusted Operating Income                               $     (34,427)         $      29,088          $       3,638          $        71,737
Diluted EPS                                             $       (0.55)         $        0.13          $       (0.42)         $          0.34
Adjusted Diluted EPS                                    $       (0.41)         $        0.18          $       (0.13)         $          0.49
Adjusted EBITDA                                         $     (14,354)         $      48,056          $      46,670          $       109,269

Percentage of net revenue:
Total costs applicable to revenue                                54.1  %                47.2  %                49.2  %                  46.5  %
Selling, general and administrative                              52.5  %                42.4  %                45.3  %                  42.2  %
Total operating expenses                                         61.9  %                47.8  %                54.1  %                  47.4  %
Income (loss) from operations                                   (16.0) %                 5.1  %                (3.4) %                   6.1  %
Net income (loss)                                               (16.9) %                 2.4  %                (4.7) %                   3.1  %
Adjusted Operating Income                                       (13.2) %                 6.8  %                 0.5  %                   8.1  %
Adjusted EBITDA                                                  (5.5) %                11.2  %                 6.4  %                  12.3  %



                                       36

--------------------------------------------------------------------------------
  Table of Contents
Three Months Ended June 27, 2020 compared to Three Months Ended June 29, 2019
As a result of the COVID-19 pandemic, our retail stores closed to the public
beginning on March 19, 2020. We began reopening our stores to the public on
April 27, 2020, and on June 8, 2020, we announced the successful completion of
the reopening process.
Net revenue
The following presents, by segment and by brand, comparable store sales growth,
stores open at the end of the period and net revenue for the three months ended
June 27, 2020 compared to the three months ended June 29, 2019.
                                    Comparable store sales growth(1)                              Stores open at end of period                                         Net revenue(2)
                                                         Three Months
                                    Three Months            Ended
In thousands, except                    Ended              June 29,                                                    Three Months Ended                       Three Months Ended
percentage and store data           June 27, 2020            2019           June 27, 2020       June 29, 2019            June 27, 2020                             June 29, 2019
Owned & Host segment
America's Best                            (37.1) %             4.5  %              753                 702          $  176,196       67.8  %       $ 266,781             62.1  %
Eyeglass World                            (31.6) %             5.2  %              118                 117              30,357       11.7  %          44,059             10.3  %
Military                                  (44.6) %             0.3  %               54                  54               3,328        1.3  %           6,021              1.4  %
Fred Meyer                                (48.6) %            (5.3) %               29                  29               1,824        0.7  %           3,555              0.8  %
Owned & Host segment total                                                         954                 902          $  211,705       81.4  %       $ 320,416             74.6  %
Legacy segment                            (35.8) %             0.4  %              231                 226              25,413        9.8  %          39,264              9.1  %
Corporate/Other                               -  %               -  %                -                   -              50,472       19.4  %          62,346             14.6  %
Reconciliations                               -  %               -  %                -                   -             (27,583)     (10.6) %           7,425              1.7  %
Total                                     (44.7) %             4.4  %            1,185               1,128          $  260,007      100.0  %       $ 429,451            100.0  %
Adjusted comparable store
sales growth(3)                           (36.5) %             3.8  %


(1)We calculate total comparable store sales based on consolidated net revenue
excluding the impact of (i) corporate/other segment net revenue, (ii) sales from
stores opened less than 13 months, (iii) stores closed in the periods presented,
(iv) sales from partial months of operation when stores do not open or close on
the first day of the month and (v) if applicable, the impact of a 53rd week in a
fiscal year. Brand-level comparable store sales growth is calculated based on
cash basis revenues consistent with what the CODM reviews, and consistent with
reportable segment revenues presented in Note 10. "Segment Reporting" in our
unaudited condensed consolidated financial statements included in Part I. Item
1. of this Form 10-Q, with the exception of the legacy segment, which is
adjusted as noted in clause (ii) of footnote (3) below.
(2)Percentages reflect line item as a percentage of net revenue, adjusted for
rounding.
(3)There are two differences between total comparable store sales growth based
on consolidated net revenue and Adjusted Comparable Store Sales Growth: (i)
Adjusted Comparable Store Sales Growth includes the effect of deferred and
unearned revenue as if such revenues were earned at the point of sale, resulting
in an increase of 8.1% and a decrease of 0.4% from total comparable store sales
growth based on consolidated net revenue for the three months ended June 27,
2020 and June 29, 2019, respectively, and (ii) Adjusted Comparable Store Sales
Growth includes retail sales to the legacy partner's customers (rather than the
revenues recognized consistent with the management & services agreement with the
legacy partner), resulting in an increase of 0.1% and a decrease of 0.2% from
total comparable store sales growth based on consolidated net revenue for each
of the three months ended June 27, 2020 and June 29, 2019.
Total net revenue of $260.0 million for the three months ended June 27, 2020
decreased $169.4 million, or 39.5%, from $429.5 million for the three months
ended June 29, 2019. This decrease was driven by the closure of our stores to
the public for a portion of the three months ended June 27, 2020 and was
partially offset by new store sales. Total net revenue was also negatively
impacted by changes in unearned revenue.
In the three months ended June 27, 2020, we opened 11 America's Best stores and
one Eyeglass World store and closed five America's Best stores; we also
transitioned five additional Legacy stores to our management. Overall, store
count grew 5.1% from June 29, 2019 to June 27, 2020 (51, one and five net new
America's Best, Eyeglass World and Legacy stores were added, respectively).
                                       37
--------------------------------------------------------------------------------
  Table of Contents
Comparable store sales growth and Adjusted Comparable Store Sales Growth for the
three months ended June 27, 2020 were (44.7)% and (36.5)%, respectively. The
decreases in comparable store sales growth and Adjusted Comparable Store Sales
Growth were primarily driven by the temporary closure of our stores to the
public in response to the COVID-19 pandemic. Comparable store sales growth and
Adjusted Comparable Store Sales Growth for the one month ended April 25, 2020
were (83.9)% and (86.6)%, respectively. Comparable store sales growth and
Adjusted Comparable Store Sales Growth for the one month ended May 30, 2020 were
(56.6)% and (38.5)%, respectively. Comparable store sales growth and Adjusted
Comparable Store Sales Growth for the one month ended June 27, 2020 were 14.3%
and 19.3%, respectively. Adjusted Comparable Store Sales Growth includes the
effect of deferred and unearned revenue as if such revenues were earned at the
point of sale, resulting in a decrease of 3.3%, an increase of 17.7% and an
increase of 6.0% for the one month periods ended April 25, 2020, May 30, 2020
and June 27, 2020, respectively. Adjusted Comparable Store Sales Growth includes
retail sales to the legacy partner's customers (rather than the revenues
recognized consistent with the management & services agreement with the legacy
partner), resulting in an increase of 0.6%, an increase of 0.4% and a decrease
of 1.0% for the one month periods ended April 25, 2020, May 30, 2020 and June
27, 2020, respectively.
Net product sales comprised 80.7% and 83.3% of total net revenue for the three
months ended June 27, 2020 and June 29, 2019, respectively. Net product sales
decreased $147.8 million, or 41.3%, in the three months ended June 27, 2020
compared to the three months ended June 29, 2019, driven primarily by the
temporary closure of our stores to the public in response to the COVID-19
pandemic. Net sales of services and plans decreased $21.6 million, or 30.1%,
driven primarily by the temporary closure of our stores to the public in
response to the COVID-19 pandemic.
Owned & Host segment net revenue. Net revenue decreased $108.7 million, or
33.9%, due to the temporary closure of our stores to the public in response to
the COVID-19 pandemic.
Legacy segment net revenue. Net revenue decreased $13.9 million, or 35.3% due to
the temporary closure of our stores to the public in response to the COVID-19
pandemic.
Corporate/Other segment net revenue. Net revenue decreased $11.9 million, or
19.0%, driven by reductions in wholesale fulfillment that was partially offset
by increases in our online retail business.
Net revenue reconciliations. The impact of reconciliations decreased net revenue
by $35.0 million for the three months ended June 27, 2020 compared to the three
months ended June 29, 2019. Reconciliations include an increase in unearned
revenue of $34.4 million compared to a decrease in unearned revenue of $8.5
million for the three months ended June 27, 2020 and June 29, 2019,
respectively, as well as a decrease in deferred revenue of $6.9 million and an
increase of $1.1 million for the three months ended June 27, 2020 and June 29,
2019, respectively. The increase in unearned revenue for the three months ended
June 27, 2020 resulted from the temporary closure of our stores to the public at
the end of the first quarter of 2020 as well as stronger sales at the end of the
second quarter of 2020.
Costs applicable to revenue
Costs applicable to revenue of $140.8 million for the three months ended June
27, 2020 decreased $61.7 million, or 30.5%, from $202.5 million for the three
months ended June 29, 2019. As a percentage of net revenue, costs applicable to
revenue increased from 47.2% for the three months ended June 29, 2019 to 54.1%
for the three months ended June 27, 2020. This increase as a percentage of net
revenue was primarily driven by optometrist costs incurred during temporary
store closures and increased contact lens mix.
Costs of products as a percentage of net product sales increased from 40.7% for
the three months ended June 29, 2019 to 46.6% for the three months ended June
27, 2020, primarily driven by increased contact lens mix.
Owned & Host segment costs of products. Costs of products as a percentage of net
product sales increased from 29.5% for the three months ended June 29, 2019 to
30.9% for the three months ended June 27, 2020. The increase was primarily
driven by increased contact lens mix in the three months ended June 27, 2020.
Legacy segment costs of products. Costs of products as a percentage of net
product sales increased from 47.7% for the three months ended June 29, 2019 to
55.9% for the three months ended June 27, 2020. The increase was primarily
driven by increased contact lens mix and by a higher mix of non-managed care
customer transactions versus managed care customer transactions. Legacy segment
managed care net product revenue is recorded in net product sales while revenue
associated with servicing non-managed care customers is recorded in net sales of
services and plans. Eyeglass and contact lens product costs for both managed
care and non-managed care net revenue are recorded in costs of products.
Decreases in managed care mix increase costs of products as a percentage of net
product sales and have a corresponding positive impact on costs of services as a
percentage of net sales of services and plans in our Legacy segment.
                                       38
--------------------------------------------------------------------------------
  Table of Contents
Costs of services and plans as a percentage of net sales of services and plans
increased from 79.1% for the three months ended June 29, 2019 to 85.8% for the
three months ended June 27, 2020. The increase was primarily driven by
optometrist costs incurred while our stores were temporarily closed to the
public in response to the COVID-19 pandemic.
Owned & Host segment costs of services and plans. Costs of services and plans as
a percentage of net sales of services and plans in the owned & host segment
increased from 84.9% for the three months ended June 29, 2019 to 112.5% for the
three months ended June 27, 2020. The increase was driven primarily by
optometrist costs incurred while our stores were temporarily closed to the
public in response to the COVID-19 pandemic.
Legacy segment costs of services and plans. Costs of services and plans as a
percentage of net sales of services and plans increased from 46.5% for the three
months ended June 29, 2019 to 49.9% for the three months ended June 27, 2020.
The increase was primarily driven by optometrist costs incurred while our stores
were temporarily closed to the public in response to the COVID-19 pandemic.
Selling, general and administrative
SG&A of $136.6 million for the three months ended June 27, 2020 decreased $45.7
million, or 25.1%, from the three months ended June 29, 2019. As a percentage of
net revenue, SG&A increased from 42.4% for the three months ended June 29, 2019
to 52.5% for the three months ended June 27, 2020. The increase in SG&A as a
percentage of net revenue was primarily driven by store and corporate payroll
and occupancy expenses incurred while our stores were temporarily closed to the
public in response to the COVID-19 pandemic, partially offset by lower
advertising expense. SG&A for the three months ended June 27, 2020 includes $2.5
million of incremental costs directly related to adapting the Company's
operations during the COVID-19 pandemic; these costs were not reflected as
adjustments for the Company's presentation of non-GAAP measures below.
Owned & Host SG&A. SG&A as a percentage of net revenue increased from 39.3% for
the three months ended June 29, 2019 to 41.0% for the three months ended June
27, 2020, driven primarily by store payroll and occupancy costs incurred while
our stores were temporarily closed to the public in response to the COVID-19
pandemic, partially offset by lower advertising expense.
Legacy segment SG&A. SG&A as a percentage of net revenue increased from 35.4%
for the three months ended June 29, 2019 to 41.6% for the three months ended
June 27, 2020, driven primarily by store payroll costs incurred while our stores
were temporarily closed to the public in response to the COVID-19 pandemic.
Depreciation and amortization
Depreciation and amortization expense of $21.9 million for the three months
ended June 27, 2020 increased $1.1 million, or 5.3%, from $20.8 million for the
three months ended June 29, 2019 primarily driven by new store openings. Our
property and equipment balance, net, decreased $9.9 million, or 2.8%, during the
three months ended June 27, 2020, reflective of $11.8 million in purchases of
property and equipment less $20.1 million in depreciation expense and $1.6
million in impairment and other adjustments.
Asset Impairment
We recognized $2.4 million for impairment primarily of tangible long-lived
assets and ROU assets associated with our retail stores during the three months
ended June 27, 2020, compared to $1.8 million recognized during the three months
ended June 29, 2019. The impairment charges were primarily related to our Owned
& Host segment, caused by lower than projected customer sales volume in certain
stores, and were determined using entity-specific assumptions related to our
anticipated use of store assets. We considered multiple factors including, but
not limited to: forecasted scenarios related to store performance and likelihood
that these scenarios would be ultimately realized; the historical performance of
the stores before the temporary store closures in response to the COVID-19
pandemic; and the remaining useful lives of the assets. The asset impairment
expense for the three months ended June 27, 2020 also includes $1.1 million
related to a write-off of certain software assets that were deemed to be
obsolete. Asset impairment expenses were recognized in Corporate/Other.
Interest expense, net
Interest expense, net, of $15.5 million for the three months ended June 27, 2020
increased $6.5 million, or 72.9%, from $9.0 million for the three months ended
June 29, 2019. The increase was primarily driven by losses related to changes in
fair value of derivatives due to ineffectiveness of $4.9 million and charges
related to interest payments and amortization of debt discounts related to the
2025 Notes of $2.3 million that were partially offset by a reduction in our term
loan and revolving credit facility utilization.
                                       39
--------------------------------------------------------------------------------
  Table of Contents
Income tax provision
Our income tax expense for the three months ended June 27, 2020 reflected our
statutory federal and state rate of 25.5%, offset by a discrete benefit of $0.3
million associated primarily with the exercise of stock options. In comparison,
the income tax rate associated with the three months ended June 29, 2019
reflected income tax expense at our statutory federal and state rate of 25.6%
and was reduced by a $1.1 million income tax benefit resulting from stock option
exercises.
Six Months Ended June 27, 2020 compared to Six Months Ended June 29, 2019
As a result of the COVID-19 pandemic, our retail stores closed to the public
beginning on March 19, 2020. We began reopening our stores to the public on
April 27, 2020, and on June 8, 2020, we announced the successful completion of
the reopening process.
Net revenue
The following presents, by segment and by brand, comparable store sales growth,
stores open at the end of the period and net revenue for the six months ended
June 27, 2020 compared to the six months ended June 29, 2019.
                                     Comparable store sales growth(1)                                 Stores open at end of period                                           Net revenue(2)
                                                           Six Months
In thousands, except               Six Months Ended           Ended                                                         Six Months Ended                           Six Months Ended
percentage and store data           June 27, 2020         June 29, 2019       June 27, 2020       June 29, 2019              June 27, 2020                               June 29, 2019
Owned & Host segment
America's Best                             (22.2) %              6.4  %              753                 702          $      470,366       64.5  %       $ 571,877             64.2  %
Eyeglass World                             (21.2) %              5.9  %              118                 117                  74,843       10.3  %          94,273             10.6  %
Military                                   (27.8) %             (2.2) %               54                  54                   8,970        1.2  %          12,442              1.4  %
Fred Meyer                                 (32.5) %             (7.5) %               29                  29                   4,753        0.7  %           7,044              0.8  %
Owned & Host segment total                                                           954                 902          $      558,932       76.6  %       $ 685,636             77.0  %
Legacy segment                             (24.4) %              1.1  %              231                 226                  61,870        8.5  %          83,842              9.4  %
Corporate/Other                                -                   -                   -                   -                 117,044       16.0  %         126,227             14.2  %
Reconciliations                                -                   -                   -                   -                  (8,135)      (1.1) %          (5,039)            (0.6) %
Total                                      (23.0) %              5.4  %            1,185               1,128          $      729,711      100.0  %       $ 890,666            100.0  %
Adjusted Comparable Store
Sales Growth(3)                            (22.6) %              5.3  %


(1)We calculate total comparable store sales based on consolidated net revenue
excluding the impact of (i) Corporate/Other segment net revenue, (ii) sales from
stores opened less than 13 months, (iii) stores closed in the periods presented,
(iv) sales from partial months of operation when stores do not open or close on
the first day of the month and (v) if applicable, the impact of a 53rd week in a
fiscal year. Brand-level comparable store sales growth is calculated based on
cash basis revenues consistent with what the CODM reviews, and consistent with
reportable segment revenues presented in Note 10. "Segment Reporting" in our
unaudited condensed consolidated financial statements included in Part I. Item
1. of this Form 10-Q, with the exception of the Legacy segment, which is
adjusted as noted in clause (ii) of footnote (3) below.
(2)Percentages reflect line item as a percentage of net revenue, adjusted for
rounding.
(3)There are two differences between total comparable store sales growth based
on consolidated net revenue and Adjusted Comparable Store Sales Growth: (i)
Adjusted Comparable Store Sales Growth includes the effect of deferred and
unearned revenue as if such revenues were earned at the point of sale, resulting
in an increase of 0.3% and an increase of 0.2% from total comparable store sales
growth based on consolidated net revenue for the six months ended June 27, 2020
and June 29, 2019, respectively, and (ii) Adjusted Comparable Store Sales Growth
includes retail sales to the legacy partner's customers (rather than the
revenues recognized consistent with the management & services agreement with the
legacy partner), resulting in an increase of 0.1% and a decrease of 0.3% from
total comparable store sales growth based on consolidated net revenue for the
six months ended June 27, 2020 and June 29, 2019, respectively.
Total net revenue of $729.7 million for the six months ended June 27, 2020
decreased $161.0 million, or 18.1%, from $890.7 million for the six months ended
June 29, 2019. This decrease was driven by the closure of our stores to the
public for a portion of the six months ended June 27, 2020 and was partially
offset by new store sales. Total net revenue was also negatively impacted by
changes in unearned revenue.
In the six months ended June 27, 2020, we opened 34 new America's Best stores
and one Eyeglass World store and closed six America's Best stores; we also
transitioned five additional Legacy stores to our management. Overall, store
count grew 5.1% from June 29, 2019 to June 27, 2020 (51, one and five net new
America's Best, Eyeglass World and Legacy stores, respectively, were added
during the same period).
                                       40
--------------------------------------------------------------------------------
  Table of Contents
Comparable store sales growth and Adjusted Comparable Store Sales Growth for the
six months ended June 27, 2020 were (23.0)% and (22.6)%, respectively. The
decreases in comparable store sales growth and Adjusted Comparable Store Sales
Growth were primarily driven by the temporary closure of our stores to the
public in response to the COVID-19 pandemic.
Net product sales comprised 82.6% and 83.2% of total net revenue for the six
months ended June 27, 2020 and June 29, 2019, respectively. Net product sales
decreased $138.1 million, or 18.7%, in the six months ended June 27, 2020
compared to the six months ended June 29, 2019, driven primarily by decreased
eyeglass sales. Net sales of services and plans decreased $22.8 million, or
15.2%, primarily due to the temporary closure of stores to the public in
response to the COVID-19 pandemic.
Owned & Host segment net revenue. Net revenue decreased $126.7 million, or
18.5%, due to the temporary closure of our stores to the public in response to
the COVID-19 pandemic.
Legacy segment net revenue. Net revenue decreased $22.0 million, or 26.2%, due
to the temporary closure of our stores to the public in response to the COVID-19
pandemic.
Corporate/Other segment net revenue. Net revenue decreased $9.2 million, or
7.3%, driven by lower wholesale fulfillment, partially offset by growth in our
online retail business.
Net revenue reconciliations. The impact of reconciliations decreased net revenue
by $3.1 million in the six months ended June 27, 2020 compared to the six months
ended June 29, 2019. Reconciliations include an increase in unearned revenue of
$14.5 million for the six months ended June 27, 2020 compared to a decrease in
unearned revenue of $0.8 million for the six months ended June 29, 2019, and a
decrease in deferred revenue of $6.4 million compared to an increase of $5.8
million, for the six months ended June 27, 2020 and June 29, 2019, respectively.
We believe that the increase in unearned revenue reflects the effects of our
store closures that began on March 19, 2020 and continued through a portion of
the second quarter of 2020, as customers were unable to make eyeglass purchases
during the last seven to 10 days of the first quarter of 2020, but then returned
to the stores once they had reopened and made purchases reflective of demand
that was not met during the temporary closure period.
Costs applicable to revenue
Costs applicable to revenue of $359.3 million for the six months ended June 27,
2020 decreased $55.1 million, or 13.3%, from $414.5 million for the six months
ended June 29, 2019. As a percentage of net revenue, costs applicable to revenue
increased from 46.5% for the six months ended June 29, 2019 to 49.2% for the six
months ended June 27, 2020. This increase as a percentage of net revenue was
primarily driven by optometrist costs incurred during the temporary closure of
our stores to the public in response to the COVID-19 pandemic as well as
increased contact lens mix that was partially offset by higher eyeglass margin.
Costs of products as a percentage of net product sales increased from 40.5% for
the six months ended June 29, 2019 to 42.2% for the six months ended June 27,
2020, driven primarily by increased contact lens mix that was partially offset
by higher eyeglass margin.
Owned & Host segment costs of products. Costs of products as a percentage of net
product sales increased from 29.1% for the six months ended June 29, 2019 to
29.8% for the six months ended June 27, 2020 driven by increased contact lens
mix that was partially offset by higher eyeglass margin.
Legacy segment costs of products. Costs of products as a percentage of net
product sales increased from 47.3% for the six months ended June 29, 2019 to
50.4% for the six months ended June 27, 2020. The increase was primarily driven
by increased contact lens mix and by a higher mix of non-managed care customer
transactions. Decreases in managed care mix increase costs of products as a
percentage of net product sales and have a corresponding positive impact on
costs of services as a percentage of net sales of services and plans in our
Legacy segment. Legacy segment managed care net product revenue is recorded in
net product sales while revenue associated with servicing non-managed care
customers is recorded in net sales of services and plans. Eyeglass and contact
lens product costs for both managed care and non-managed care net revenue are
recorded in costs of products.
Costs of services and plans as a percentage of net sales of services and plans
increased from 76.6% for the six months ended June 29, 2019 to 82.8% for the six
months ended June 27, 2020. The increase was primarily driven by optometrist
costs incurred during the temporary closure of our stores to the public in
response to the COVID-19 pandemic.
                                       41
--------------------------------------------------------------------------------
  Table of Contents
Owned & Host segment costs of services and plans. Costs of services and plans as
a percentage of net sales of services and plans increased from 80.0% for the six
months ended June 29, 2019 to 94.6% for the six months ended June 27, 2020. The
increase was driven by optometrist and technician costs incurred during the
temporary closure of our stores to the public in response to the COVID-19
pandemic.
Legacy segment costs of services and plans. Costs of services and plans as a
percentage of net sales of services and plans increased from 45.0% for the six
months ended June 29, 2019 to 52.7% for the six months ended June 27, 2020. The
increase was primarily driven by optometrist costs incurred during the temporary
closure of our stores to the public in response to the COVID-19 pandemic.
Selling, general and administrative
SG&A of $330.3 million for the six months ended June 27, 2020 decreased $45.8
million, or 12.2%, from the six months ended June 29, 2019. As a percentage of
net revenue, SG&A increased from 42.2% for the six months ended June 29, 2019 to
45.3% for the six months ended June 27, 2020. The increase in SG&A as a
percentage of net revenue was primarily due to store and corporate payroll and
occupancy costs incurred during the temporary closure of our stores to the
public in response to the COVID-19 pandemic, partially offset by lower
advertising expense. SG&A for the six months ended June 27, 2020 includes $3.1
million of incremental costs directly related to adapting the Company's
operations during the COVID-19 pandemic; of these costs, $0.6 million were
reflected as adjustments for the Company's presentation of non-GAAP measures
below.
Owned & Host SG&A. SG&A as a percentage of net revenue increased from 37.8% for
the six months ended June 29, 2019 to 39.6% for the six months ended June 27,
2020, driven primarily by store payroll and occupancy costs incurred during the
temporary closure of our stores to the public in response to the COVID-19
pandemic, which were partially offset by reduced advertising expense.
Legacy segment SG&A. SG&A as a percentage of net revenue increased from 33.5%
for the six months ended June 29, 2019 to 39.1% for the six months ended June
27, 2020 primarily driven by store payroll costs incurred during the temporary
closure of our stores to the public in response to the COVID-19 pandemic.
Depreciation and amortization
Depreciation and amortization expense of $46.7 million for the six months ended
June 27, 2020 increased $5.5 million, or 13.3%, from $41.2 million for the six
months ended June 29, 2019 primarily driven by new store openings and
investments in new lab equipment. Our property and equipment balance, net,
decreased $26.9 million, or 7.3%, during the six months ended June 27, 2020,
reflective of $28.0 million in purchases of property and equipment, $1.3 million
in new finance leases, less $43.0 million in depreciation expense, and $13.2
million in impairment expense and other adjustments.
Asset Impairment
We recognized $13.8 million for impairment primarily of tangible long-lived
assets and ROU assets associated with our retail stores during the six months
ended June 27, 2020 compared to $3.9 million recognized during the six months
ended June 29, 2019. The impairment charges were primarily related to our Owned
& Host segment and were driven by lower than projected customer sales volume in
certain stores, and were determined using entity-specific assumptions related to
our anticipated use of store assets. We considered multiple factors including,
but not limited to: forecasted scenarios related to store performance and
likelihood that these scenarios would be ultimately realized; the historical
performance of the stores before the temporary store closures in response to the
COVID-19 pandemic; and the remaining useful lives of the assets. The asset
impairment expense for the six months ended June 27, 2020 also includes $1.1
million related to a write-off of certain software assets that were deemed to be
obsolete. Asset impairment expenses were recognized in Corporate/Other.
Interest expense, net
Interest expense, net, of $23.0 million for the six months ended June 27, 2020
increased $4.9 million, or 27.3%, from $18.0 million for the six months ended
June 29, 2019. The increase was primarily driven by losses related to changes in
fair value of derivatives due to ineffectiveness of $4.9 million and charges
related to interest payments and amortization of debt discounts related to the
2025 Notes of $2.3 million that were partially offset by a reduction in our term
loan and revolving credit facility utilization.
Income tax provision
                                       42
--------------------------------------------------------------------------------
  Table of Contents
Our income tax expense for the six months ended June 27, 2020 reflected our
statutory federal and state rate of 25.5%, offset by a discrete benefit of $3.0
million associated primarily with the exercise of stock options. In comparison,
the income tax rate associated with the six months ended June 29, 2019 reflected
income tax expense at our statutory federal and state rate of 25.6% and was
reduced by a $1.4 million income tax benefit resulting from stock option
exercises.

Non-GAAP Financial Measures
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Operating Income,
Adjusted Operating Margin and Adjusted Diluted EPS
We define EBITDA as net income (loss), plus interest expense, income tax
provision (benefit) and depreciation and amortization. We define Adjusted EBITDA
as net income (loss), plus interest expense, income tax provision (benefit) and
depreciation and amortization, further adjusted to exclude stock compensation
expense, asset impairment, litigation settlement, management realignment
expenses, long-term incentive plan expenses, and other expenses. We define
Adjusted EBITDA Margin as Adjusted EBITDA as a percentage of net revenue. We
define Adjusted Operating Income as net income (loss), plus interest expense and
income tax provision (benefit), further adjusted to exclude stock compensation
expense, asset impairment, litigation settlement, management realignment
expenses, long-term incentive plan expenses, amortization of acquisition
intangibles, and other expenses. We define Adjusted Operating Margin as Adjusted
Operating Income as a percentage of net revenue. We define Adjusted Diluted EPS
as diluted earnings (loss) per share, adjusted for the per share impact of stock
compensation expense, asset impairment, litigation settlement, management
realignment expenses, long-term incentive plan expenses, amortization of
acquisition intangibles, amortization of debt discount and deferred financing
costs, losses (gains) on change in fair value of derivatives, other expenses,
and tax benefit of stock option exercises, less the tax effect of these
adjustments.
In the first quarter of 2020, we introduced Adjusted Operating Income and
Adjusted Operating Margin as measures of performance we will use in connection
with Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Diluted EPS. Further,
consistent with our presentation of Adjusted Operating Income, we no longer
exclude new store pre-opening expenses and non-cash rent from our presentation
of Adjusted EBITDA and Adjusted Diluted EPS. New store pre-opening expenses
totaled $0.4 million and $1.1 million for the three months ended June 27, 2020
and June 29, 2019, respectively; $1.3 million and $2.0 million for the six
months ended June 27, 2020 and June 29, 2019, respectively; and non-cash rent
totaled $0.9 million and $0.7 million for the three months ended June 27, 2020
and June 29, 2019, respectively; and $1.5 million and $1.8 million for the six
months ended June 27, 2020 and June 29, 2019, respectively. The presentation of
Adjusted EBITDA and Adjusted Diluted EPS for the three and six months ended June
29, 2019 has been recast to reflect these changes. See our Form 8-K filed with
the SEC on February 26, 2020, which is incorporated herein by reference, for
more information.
EBITDA and the Company Non-GAAP Measures can vary substantially in size from one
period to the next, and certain types of expenses are non-recurring in nature
and consequently may not have been incurred in any of the periods presented
below.
EBITDA and the Company Non-GAAP Measures have been presented as supplemental
measures of financial performance that are not required by, or presented in
accordance with U.S. GAAP, because we believe they assist investors and analysts
in comparing our operating performance across reporting periods on a consistent
basis by excluding items that we do not believe are indicative of our core
operating performance. Management believes EBITDA and the Company Non-GAAP
Measures are useful to investors in highlighting trends in our operating
performance, while other measures can differ significantly depending on
long-term strategic decisions regarding capital structure, the tax jurisdictions
in which we operate and capital investments. We also use EBITDA and the Company
Non-GAAP Measures to supplement U.S. GAAP measures of performance in the
evaluation of the effectiveness of our business strategies, to make budgeting
decisions, to establish discretionary annual incentive compensation and to
compare our performance against that of other peer companies using similar
measures. Management supplements U.S. GAAP results with Non-GAAP financial
measures to provide a more complete understanding of the factors and trends
affecting the business than U.S. GAAP results alone.
                                       43
--------------------------------------------------------------------------------
  Table of Contents
EBITDA and the Company Non-GAAP Measures are not recognized terms under U.S.
GAAP and should not be considered as an alternative to net income or income from
operations as a measure of financial performance or cash flows provided by
operating activities as a measure of liquidity, or any other performance measure
derived in accordance with U.S. GAAP. Additionally, these measures are not
intended to be a measure of free cash flow available for management's
discretionary use as they do not consider certain cash requirements such as
interest payments, tax payments and debt service requirements. EBITDA and the
Company Non-GAAP Measures should not be construed to imply that our future
results will be unaffected by unusual or non-recurring items. In evaluating
EBITDA and the Company Non-GAAP Measures you should be aware that in the future
we may incur expenses that are the same as or similar to some of the adjustments
in this presentation. Our presentation of EBITDA and the Company Non-GAAP
Measures should not be construed to imply that our future results will be
unaffected by any such adjustments. Management compensates for these limitations
by primarily relying on our U.S. GAAP results in addition to using EBITDA and
the Company Non-GAAP Measures.
The presentations of these measures have limitations as analytical tools and
should not be considered in isolation, or as a substitute for analysis of our
results as reported under U.S. GAAP. Some of these limitations are:
•they do not reflect costs or cash outlays for capital expenditures or
contractual commitments;
•they do not reflect changes in, or cash requirements for, our working capital
needs;
•EBITDA and Adjusted EBITDA do not reflect the interest expense, or the cash
requirements necessary to service interest or principal payments, on our debt;
•EBITDA and Adjusted EBITDA do not reflect period to period changes in taxes,
income tax expense or the cash necessary to pay income taxes;
•they do not reflect the impact of earnings or charges resulting from matters we
consider not to be indicative of our ongoing operations;
•although depreciation and amortization are non-cash charges, the assets being
depreciated and amortized will often have to be replaced in the future, and
EBITDA and Adjusted EBITDA do not reflect cash requirements for such
replacements; and
•other companies in our industry may calculate these measures differently than
we do, limiting their usefulness as comparative measures.
Because of these limitations, EBITDA and the Company Non-GAAP Measures should
not be considered as measures of discretionary cash available to invest in
business growth or to reduce indebtedness.
The following table reconciles our Adjusted Operating Income and Adjusted
Operating Margin to net income; and EBITDA, Adjusted EBITDA, Adjusted EBITDA
Margin and Adjusted Diluted EPS for the periods presented:
                                                     Three Months Ended                                                                                  Six Months Ended
                                                                                                                                                                     June 29,
In thousands                            June 27, 2020                               June 29, 2019                               June 27, 2020                          2019
Net income (loss)                $     (43,833)     (16.9)%         $ 10,257       2.4%               $ (34,091)    (4.7)%            $ 27,686      3.1%
Interest expense                        15,502       6.0%              8,968       2.1%                  22,957      3.1%               18,029      2.0%
Income tax provision (benefit)         (13,403)     (5.2)%             2,477       0.6%                 (13,685)    (1.9)%               8,387     

0.9%


Stock compensation expense (a)           3,352       1.3%              1,741       0.4%                   5,445      0.7%                4,717      0.5%
Asset impairment (b)                     2,411       0.9%              1,790       0.4%                  13,766      1.9%                3,872      0.4%
Litigation settlement (c)                    -        -%                   -        -%                    4,395      0.6%                    -       -%
Management realignment expenses
(d)                                          -        -%                   -        -%                        -       -%                 2,155      0.2%
Long-term incentive plan (e)                 -        -%                 781       0.2%                       -       -%                   722      0.1%
Amortization of acquisition
intangibles (f)                          1,851       0.7%              1,851       0.4%                   3,702      0.5%                3,702      0.4%
Other (i)                                 (307)     (0.1)%             1,223       0.3%                   1,149      0.2%                2,467      0.3%
Adjusted Operating Income /
Adjusted Operating Margin        $     (34,427)     (13.2)%         $ 29,088       6.8%               $   3,638      0.5%             $ 71,737      8.1%

Note: Percentages reflect line item as a percentage of net revenue, adjusted for rounding.

Some of the percentage totals in the table above do not foot due to rounding differences.


                                       44

--------------------------------------------------------------------------------


  Table of Contents
                                                   Three Months Ended                                                                              Six Months Ended
                                                                                                                                                               June 29,
In thousands                           June 27, 2020                           June 29, 2019                             June 27, 2020                           2019

Net income (loss)                $    (43,833)    (16.9) %       $ 10,257         2.4  %       $ (34,091)    (4.7)%           $  27,686       3.1%
Interest expense                       15,502       6.0  %          8,968         2.1  %          22,957      3.1%               18,029       2.0%

Income tax provision (benefit) (13,403) (5.2) % 2,477

       0.6  %         (13,685)    (1.9)%               8,387       0.9%

Depreciation and amortization 21,924 8.4 % 20,819

       4.8  %          46,734      6.4%               41,234       4.6%
EBITDA                                (19,810)     (7.6) %         42,521         9.9  %          21,915      3.0%               95,336      10.7%

Stock compensation expense (a) 3,352 1.3 % 1,741


      0.4  %           5,445      0.7%                4,717       0.5%
Asset impairment (b)                    2,411       0.9  %          1,790         0.4  %          13,766      1.9%                3,872       0.4%
Litigation settlement (c)                   -         -  %              -           -  %           4,395      0.6%                    -        -%
Management realignment expenses
(d)                                         -         -  %              -           -  %               -       -%                 2,155       0.2%
Long-term incentive plan (e)                -         -  %            781         0.2  %               -       -%                   722       0.1%
Other (i)                                (307)     (0.1) %          1,223         0.3  %           1,149      0.2%                2,467       0.3%
Adjusted EBITDA / Adjusted
EBITDA Margin                    $    (14,354)     (5.5) %       $ 48,056        11.2  %       $  46,670      6.4%            $ 109,269      12.3%

Note: Percentages reflect line item as a percentage of net revenue, adjusted for rounding. Some of the percentage totals in the table above do not foot due to rounding differences




                                                      Three Months Ended                                           Six Months Ended

In thousands, except per share amounts June 27, 2020 June 29, 2019 June 27, 2020 June 29, 2019 Diluted EPS

$       (0.55)         $       

0.13 $ (0.42) $ 0.34 Stock compensation expense (a)

                       0.04                  0.02                  0.07                     0.06
Asset impairment (b)                                 0.03                  0.02                  0.17                     0.05
Litigation settlement (c)                               -                     -                  0.05                        -
Management realignment expenses (d)                     -                     -                     -                     0.03
Long-term incentive plan (e)                            -                  0.01                     -                     0.01
Amortization of acquisition intangibles (f)          0.02                  0.02                  0.05                     0.05
Amortization of debt discount and deferred
financing costs (g)                                  0.03                  0.01                  0.03                     0.01
Losses (gains) on change in fair value of
derivatives (h)                                      0.06                     -                  0.06                        -
Other (i)                                               -                  0.02                  0.01                     0.03
Tax benefit of stock option exercises (j)               -                 (0.01)                (0.04)                   (0.02)
Tax effect of total adjustments (k)                 (0.05)                (0.02)                (0.12)                   (0.06)
Adjusted Diluted EPS                        $       (0.41)         $       

0.18 $ (0.13) $ 0.49



Weighted average diluted shares outstanding        80,325                81,424                80,226                   81,437

Note: Some of the totals in the table above do not foot due to rounding differences




(a)Non-cash charges related to stock-based compensation programs, which vary
from period to period depending on the timing of awards and performance vesting
conditions.
(b)Reflects write-off of property, equipment and lease related assets on closed
or underperforming stores for the three and six months ended June 27, 2020 and
June 29, 2019.
(c)Expenses associated with settlement of litigation. See Note 9. "Commitments
and Contingencies" for further details.
(d)Expenses related to a non-recurring management realignment described in our
Current Report on Form 8-K filed with the SEC on January 10, 2019.
(e)Expenses pursuant to a long-term incentive plan for non-executive employees
who were not participants in the management equity plan for fiscal year 2019.
This plan was effective in 2014 following the acquisition of the Company by
affiliates of KKR & Co. Inc. (the "KKR Acquisition").
(f)Amortization of the increase in carrying values of finite-lived intangible
assets resulting from the application of purchase accounting to the KKR
Acquisition.
                                       45
--------------------------------------------------------------------------------
  Table of Contents
(g)Amortization of debt discount is associated with the amortization of the
conversion feature related to the convertible note and amortization of deferred
financing costs relate to the convertible notes, term loan and revolving credit
facility borrowings. Amortization of debt discount and deferred financing costs
in aggregate total $2.5 million and $0.5 million for the three months ended June
27, 2020 and June 29, 2019, respectively, and $2.7 million and $0.9 million for
the six months ended June 27, 2020 and June 29, 2019, respectively.
(h)Reflects $4.9 million of losses recognized in interest expense on change in
fair value of de-designated hedges for the three and six months ended June 27,
2020.
(i)Other adjustments include amounts that management believes are not
representative of our operating performance (amounts in brackets represent
reductions in Adjusted Operating Income, Adjusted Diluted EPS and Adjusted
EBITDA), including our share of losses on equity method investments of $0.4
million for the three months ended June 29, 2019 and $1.0 million for the six
months ended June 29, 2019; the amortization impact of adjustments related to
the KKR Acquisition, (e.g., fair value of leasehold interests) of $0.1 million
for each of the three months ended June 27, 2020 and June 29, 2019, respectively
and $0.2 million for each of the six months ended June 27, 2020 and June 29,
2019, respectively; costs of severance and relocation of $0.2 million and $0.6
million for the three months ended June 27, 2020 and June 29, 2019,
respectively, and $0.5 million and $0.8 million for the six months ended June
27, 2020 and June 29, 2019, respectively; excess payroll taxes related to stock
option exercises of $0.1 million for the three months ended June 29, 2019, and
$0.3 million and $0.1 million for the six months ended June 27, 2020 and June
29, 2019, respectively; incremental costs directly related to adapting the
Company's operations during the COVID-19 pandemic of $0.6 million for the six
months ended June 27, 2020; and other expenses and adjustments totaling $(0.7)
million and $(31) thousand for the three months ended June 27, 2020 and June 29,
2019, respectively, and $(0.5) million and $0.3 million for the six months ended
June 27, 2020 and June 29, 2019, respectively.
(j)Tax benefit associated with accounting guidance requiring excess tax benefits
related to stock option exercises to be recorded in earnings as discrete items
in the reporting period in which they occur.
(k)Represents the income tax effect of the total adjustments at our combined
statutory federal and state income tax rates.

Liquidity and Capital Resources
As described in more detail below, on May 5, 2020, we entered into the Credit
Agreement Amendment with the lenders under our credit facility in order to
prevent the effects of the COVID-19 pandemic, including the temporary closure of
our stores, from creating uncertainty relative to our ability to comply with
certain financial covenants and allow the Company to focus on prudent management
of the business over the quarters ahead. In addition, on May 12, 2020, we
completed the issuance of the 2025 Notes and we used the net proceeds of this
offering to repay a portion of the outstanding borrowings on our term loan and
revolving credit facility. Our primary cash needs are for inventory, payroll,
store rent, capital expenditures associated with new stores and updating
existing stores, as well as information technology and infrastructure, including
our corporate office, distribution centers, and laboratories. We continue to
prioritize cash conservation and prudent use of cash, while safely conducting
normal operations. The most significant components of our operating assets and
liabilities are inventories, accounts receivable, prepaid expenses and other
assets, accounts payable, deferred and unearned revenue and other payables and
accrued expenses. We believe that cash on hand, cash expected to be generated
from operations and the cash available through our revolving credit facility
will be sufficient to fund our working capital requirements, liquidity
obligations, anticipated capital expenditures, and payments due under our
existing credit facilities for at least the next 12 months. The Company is
continuing to evaluate additional operational and financial measures that it may
elect to take as it continues to respond to the impact of COVID-19 on its
business. There can be no assurance whether or when any such measures will be
adopted.
As of June 27, 2020, we had $256.3 million in cash and cash equivalents and
$294.3 million of availability under our revolving credit facility, which
includes $5.7 million in outstanding letters of credit.
We purchased $25.8 million in capital items in the six months ended June 27,
2020. Approximately 80% of our capital spend is related to our expected growth
(i.e., new stores, optometric equipment, additional capacity in our optical
laboratories and distribution centers, and our IT infrastructure, including
omni-channel platform related investments). Our working capital requirements for
inventory will increase as we continue to open additional stores. We primarily
fund our working capital needs using cash provided by operations.
                                       46

--------------------------------------------------------------------------------


  Table of Contents
The following table summarizes cash flows provided by (used for) operating
activities, investing activities and financing activities for the periods
indicated:
                                                                       Six Months Ended
In thousands                                                 June 27, 2020           June 29, 2019
Cash flows provided by (used for):
Operating activities                                       $       71,420          $      119,279
Investing activities                                              (25,531)                (51,788)
Financing activities                                              171,437                  (1,624)

Net increase in cash, cash equivalents and restricted cash $ 217,326

$ 65,867




Net Cash Provided by Operating Activities
Cash flows provided by operating activities decreased $47.9 million from $119.3
million during the six months ended June 29, 2019 to $71.4 million for the six
months ended June 27, 2020. The decrease in cash provided by operating
activities consisted of a decrease in net income of $61.8 million and a decrease
of non-cash expense items of $1.9 million driven by decreases in deferred income
tax expense of $21.9 million and credit loss expense of $3.4 million offset by
increases in non-cash expense items including depreciation and amortization of
$5.5 million, asset impairment charges of $9.9 million, losses recognized for
the changes in the fair values of derivatives of $4.9 million and amortization
of loan costs of $1.8 million.
Changes in net working capital and other assets and liabilities contributed
$15.8 million in cash compared to the six months ended June 29, 2019. Increases
in accounts payable during the six months ended June 27, 2020 contributed $8.2
million in year-over-year cash, primarily due to timing of payments. Increases
in other liabilities during the six months ended June 27, 2020 contributed $33.1
million in year-over-year cash, which was driven by a $15.2 million increase in
year-over-year cash due to timing of unearned revenue during the six months
ended June 27, 2020, as well as increases in miscellaneous vendor accruals of
$6.1 million as a result of timing of payments, increases in reserves for
settlements of $4.4 million due to legal proceedings, and increases of $4.2
million due to lease concessions and deferrals.
Offsetting these items was a $3.8 million reduction in year-over-year cash
related to increases in accounts receivable balances, primarily due to the $10.8
million receivable recorded as a result of the employee retention credits made
available under the CARES Act for US employees during the six months ended June
27, 2020, and was partially offset by an $8.6 million increase in year-over-year
cash due to declines in receivables as a result of lower second quarter sales.
Decreases in deferred revenue used $12.1 million in year-over-year cash driven
by declines in our eye care club membership and purchase protection plan sales.
Increases in inventory used $1.5 million in year-over-year cash, due to timing
of forward buys and store closures. Increases in other assets used $7.9 million
in year-over-year cash driven by smaller decreases in prepaid advertising and
rent-related items during the six months ended June 27, 2020 when compared with
the six months ended June 29, 2019.
Net Cash Used for Investing Activities
Net cash used for investing activities decreased by $26.3 million, to $25.5
million, during the six months ended June 27, 2020 from $51.8 million during the
six months ended June 29, 2019. The decrease was primarily due to timing of new
store capital investments.
Net Cash Provided By (Used For) Financing Activities
Net cash provided by (used for) financing activities increased $173.1 million,
from $1.6 million use of cash during the six months ended June 29, 2019 to
$171.4 million provision of cash during the six months ended June 27, 2020. The
increase in cash provided by financing activities was primarily related to
proceeds of $548.8 million from the issuance of the 2025 Notes and borrowings on
our revolving credit facility, partially offset by principal payments on
long-term debt of $369.3 million, including repayments on our revolving credit
facility of $294.3 million during the six months ended June 27, 2020.
Term Loan and Revolving Credit Facility
As of June 27, 2020, we had $317.4 million of first lien term loan outstanding
under our credit agreement. As of June 27, 2020, we also had $294.3 million of
availability under our $300.0 million Revolving Credit Facility which includes
$5.7 million in outstanding letters of credit.
                                       47
--------------------------------------------------------------------------------
  Table of Contents
The interest rate payable on the first lien term loan is based on either LIBOR
or an alternative borrowing rate plus an additional margin that varies dependent
on NVI's consolidated first lien leverage ratio. The first lien term loan will
amortize in quarterly installments equal to 2.50% per annum in the first three
years of the loan and 5.00% per annum thereafter. As a result of the
$75.0 million pay down of the term loan and the $25.0 million principal
prepayment in 2019; we have no additional mandatory principal payments on the
term loan until maturity on July 18, 2024.
In addition, under our credit agreement we must maintain certain covenants based
on our financial results. Our credit agreement also contains covenants that,
among other things, limit NVI's ability to incur additional debt, create liens
against assets, make acquisitions, pay dividends or distributions on its stock,
merge or consolidate with another entity and transfer or sell assets. As of June
27, 2020, we were in compliance with all of our debt covenants under our credit
agreement.
May 2020 Amendment to Credit Agreement
On May 5, 2020, we entered into the Credit Agreement Amendment with the lenders
under our credit facility in order to amend certain provisions of the credit
agreement. As set forth in greater detail below, the principal purpose of the
Credit Agreement Amendment was to suspend certain financial maintenance
covenants contained in the credit agreement until testing at the end of the
second fiscal quarter of 2021. Capitalized terms used but not defined herein
shall have the meanings assigned to such terms in the credit agreement and
Amendment, as applicable.
Pursuant to the Credit Agreement Amendment, the financial covenants relating to
maintenance of a maximum Consolidated Total Debt to Consolidated EBITDA Ratio
and a minimum Consolidated Interest Coverage Ratio are suspended until testing
at the end of the second fiscal quarter of 2021. From and after such time, such
covenants will be reinstated on a modified basis so that, subject to certain
exceptions and limitations as described in the Credit Agreement Amendment, (i)
with respect to the second and third fiscal quarters of 2021, the Consolidated
Total Debt to Consolidated EBITDA Ratio shall not exceed 4.50 to 1.00 and, with
respect to the fourth fiscal quarter of fiscal 2021 and thereafter, the
Consolidated Total Debt to Consolidated EBITDA Ratio shall not exceed 4.00 to
1.00, in each case with NVI being able to elect to annualize certain quarterly
periods so that quarterly performance from fiscal 2020 is excluded and (ii) with
respect to the second fiscal quarter of 2021 and thereafter, the Consolidated
Interest Coverage Ratio shall not be less than 3.00 to 1.00. In lieu of such
financial covenants, pursuant to the Amendment NVI has agreed during the
suspension period, (i) not to have Consolidated EBITDA for any six fiscal
quarter period be less than $0, with the second fiscal quarter of 2020 permitted
to be excluded in certain circumstances, and (ii) to have a minimum level of
liquidity (defined as cash and cash equivalents plus the unused portion of the
revolving credit facility) equal to the lesser of (x) $100,000,000 and (y)
$40,000,000 plus the amount of any net proceeds from capital markets financings
during such period in excess of $75,000,000.
In addition, the Credit Agreement Amendment was amended pursuant to the
Amendment to, among other things, (i) limit the flexibility of NVI and Holdings
with respect to certain transactions during the covenant suspension period,
including the ability to declare or pay dividends, incur debt and make
investments and dispositions, (ii) require prepayments of the term loans under
certain circumstances during the covenant suspension period from the net
proceeds from debt or equity capital markets transactions by the Company (with
the amount of the term loans to be paid down equal to $75 million from the first
$400 million of capital raised and 50% of any proceeds above such amount) and
(iii) restrict NVI's ability to borrow under the revolving credit facility if
unrestricted cash and cash equivalents exceeds $50 million (and, in the event of
any such excess, to require a mandatory prepayment of such amount). Also
pursuant to the Amendment, the margins upon which interest is calculated for the
term loans were amended to a range of 1.75% to 2.75% (for LIBOR Loans) and 0.75%
to 1.75% (for ABR Loans), in each case based on NVI's Consolidated First Lien
Secured Debt to Consolidated EBITDA Ratio at such time, with such margins
subject to an increase of 50 basis points in the event that either (i) the
Company has not raised at least $135 million in additional proceeds from certain
capital markets transactions within 30 days of the date of the Credit Agreement
Amendment or (ii) Consolidated EBITDA for the most recently ended four quarters
is less than $0.
                                       48
--------------------------------------------------------------------------------
  Table of Contents
2025 Notes
In May 2020, we completed the issuance of the 2025 Notes. The 2025 Notes were
sold only to persons reasonably believed to be qualified institutional buyers in
reliance on Rule 144A under the Securities Act of 1933, as amended (the
"Securities Act"). The 2025 Notes will pay interest semi-annually in arrears on
May 15 and November 15 of each year, commencing on November 15, 2020, at an
annual rate of 2.50% and will be convertible into cash, shares of common stock
or a combination of cash and shares of common stock, at our election, based on
the applicable conversion rate at such time. The 2025 Notes have a maturity date
of May 15, 2025. Refer to Note 4. "Long-term Debt" for more information.
We received proceeds from the offering of $390.9 million, net of $11.6 million
in underwriter fees and other issuance costs.
Future cash requirements and sources of cash
The Company's capital allocation strategy, priorities and investments are
reviewed by the Company's Board of Directors considering both liquidity and
severity of impacts to the business resulting from COVID-19.
Primary sources of cash
The Company's primary source of cash to execute its growth strategy is its
operating cash flows, used to fund operations throughout the fiscal year and to
support future growth. The Company continues to operate in this period of
COVID-19 uncertainty with a healthy liquidity position and remains focused on
taking immediate, aggressive and prudent actions, including reevaluating all
expenditures, to enhance the Company's ability to meet the business' short-term
liquidity needs, in order to best position the business for its key
stakeholders, including the Company's associates, customers and shareholders.
Primary uses of cash
The Company's current capital allocation strategy is to prioritize navigating
the near-term challenges that COVID-19 presents and continuing to fund operating
activities. In response to COVID-19, the Company is taking immediate, aggressive
and prudent actions, including reevaluating all expenditures, to enhance the
Company's ability to meet the business' short-term liquidity needs and has
reduced the pace of new store openings in fiscal year 2020. As a result, over
the next twelve months, the Company expects its primary cash requirements to be
towards funding operating activities, including the acquisition of inventory,
and obligations related to compensation, leases and any lease modifications it
may exercise, taxes and other operating activities.
The Company also evaluates opportunities for investments in line with our key
initiatives that position the business for sustainable long-term growth. These
improvements may include opening new stores, improving store experiences or
investments in its omni-channel initiatives or other technology opportunities.
In addition, the Company evaluates store closures, including options to
terminate store leases early at certain underperforming locations. Historically,
the Company has utilized free cash flow generated from operations to fund any
discretionary capital expenditures, which have been prioritized towards new
store openings, as well as digital and omni-channel investments, information
technology, and other projects.
When appropriate, the Company may utilize excess liquidity, towards debt service
requirements, including voluntary debt prepayments, or required interest and
principal payments, if any, based on excess cash flows.
Off-balance Sheet Arrangements
We follow U.S. GAAP in making the determination as to whether or not to record
an asset or liability related to our arrangements with third parties. Consistent
with current accounting guidance, we do not record an asset or liability
associated with long-term purchase, marketing and promotional commitments, or
commitments to philanthropic endeavors. We have disclosed the amount of future
commitments associated with these items in our fiscal year 2019 annual
consolidated financial statements filed on the Form 10-K. We were not a party to
any other off-balance sheet arrangements.
Contractual Obligations
As a result of the $75 million prepayment of debt principal this quarter, the
Company does not owe principal payments on its term loan until 2024. There were
no other material changes outside the ordinary course of business in our
contractual obligations and commercial commitments from those reported as of
December 28, 2019 in the 2019 Annual Report on Form 10-K, except for the 2025
Notes issued in the second quarter of 2020 and due on May 15, 2025.
                                       49
--------------------------------------------------------------------------------
  Table of Contents
Critical Accounting Policies and Estimates
Management has evaluated the accounting policies used in the preparation of the
Company's unaudited condensed consolidated financial statements and related
notes and believes those policies to be reasonable and appropriate. Certain of
these accounting policies require the application of significant judgment by
management in selecting appropriate assumptions for calculating financial
estimates. By their nature, these judgments are subject to an inherent degree of
uncertainty. These judgments are based on historical experience, trends in the
industry, information provided by customers and information available from other
outside sources, as appropriate. The most significant areas involving management
judgments and estimates may be found in the 2019 Annual Report on Form 10-K, in
the "Critical Accounting Policies and Estimates" section of "Management's
Discussion and Analysis of Financial Condition and Results of Operations." There
have been no material changes to our critical accounting policies as compared to
the critical accounting policies described in the 2019 Annual Report on Form
10-K, except for the adoption of Accounting Standards Update ("ASU") No.
2016-13, Measurement of Credit Losses on Financial Instruments, and ASU No.
2018-15, Customer's Accounting for Implementation Costs Incurred in
a Cloud Computing Arrangement That Is a Service Contract. These changes are
discussed in Note 1. "Description of Business and Basis of Presentation" of our
unaudited condensed consolidated financial statements included in Part I. Item
1. of this Form 10-Q.
Adoption of New Accounting Pronouncements
The information set forth in Note 1. "Description of Business and Basis of
Presentation" to our unaudited condensed consolidated financial statements under
Part I. Item 1. under the heading "Adoption of New Accounting Pronouncements" of
this Form 10-Q is incorporated herein by reference.
                                       50

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses